A Phase 2A Dose-Escalation Study of the Safety, Tolerability, Pharmacokinetics and Haemodynamic Effects of BMS-986231 in Hospitalized Patients with Heart Failure with Reduced Ejection Fraction
Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy
BM-12,434
BMS‐180560, an insurmountable inhibitor of angiotensin II‐stimulated responses: comparison with losartan and EXP3174
BMS-204352
BM 106428およびBM 106172
BM Revisited
牛ロース芯への新適応二値化処理を用いた画像解析によるBMSの判定
BM-90
Future of BM